Equine drug thresholds; per se
Source version current through Jul 15, 2022
Source details
- NYCRR title agency
- Executive Department
- Section status
- Section source receipt
- Source version current through
- Jul 15, 2022
- Text saved
- Sep 13, 2026
- Publisher current-through date
- Jul 15, 2022
- Source captured
- Sep 13, 2026
- Stored text comparison
- Matches the captured source text
- Related Register notice
- SGC-09-21-00012-A · Adopted rule
- Related notice published
- Jun 2, 2021
- Related notice effective date
- Jun 2, 2021
(a)A horse shall have raced in violation of this section if any of the following substances is found, by the laboratory conducting tests for the commission, to be present in a race-day urine or blood sample taken from such horse at a concentration in excess of a threshold listed below. The test result of such laboratory shall include an assessment of the measurement uncertainty and imprecision of the quantitative threshold for the substance.
(1)Acepromazine: 10 ng/ml HEPS in urine;
(2)Albuterol: 1 ng/ml in urine;
(3)Betamethasone: 10 pg/ml in plasma;
(4)Butorphanol:
(i)300 ng/ml of total butorphanol in urine; or
(ii)2 ng/ml of free butorphanol in plasma;
(5)Cetirizine: 6 ng/ml in plasma;
(6)Cimetidine: 400 ng/ml in plasma;
(7)Clenbuterol:
(i)140 pg/ml in urine; or
(ii)any clenbuterol in plasma;
(8)Cobalt: 50 ng/ml in plasma;
(9)Dantrolene: 100 pg/ml of 5-hydroxydantrolene in plasma;
(10)Detomidine:
(i)2ng/ml of any metabolite of detomidine in urine; or
(ii)1 ng/ml of detomidine in plasma;
(11)Dexamethasone: 5 pg/ml in plasma;
(12)Diclofenac: 5 ng/ml in plasma;
(13)DMSO: 10 mcg/ml in plasma;
(14)Firocoxib: 20 ng/ml in plasma;
(15)Flunixin: 5 ng/ml in plasma;
(16)Furosemide: 100 ng/ml in plasma and a specific gravity of urine less than 1.010;
(17)Glycopyrrolate: 3 pg/ml in plasma;
(18)Guaifenesin: 12 ng/ml in plasma;
(19)Isoflupredone: 100 pg/ml in plasma;
(20)Ketoprofen: 2 ng/ml in plasma;
(21)Lidocaine: 20 pg/ml of total 3-hydroxylidocaine in plasma;
(22)Mepivacaine:
(i)10 ng/ml of total hydroxymepivacaine in urine; or
(ii)any hydroxymepivacaine in plasma;
(23)Methocarbamol: 1 ng/ml in plasma;
(24)Methylprednisolone: 100 pg/ml in plasma;
(25)Omeprazole: 10 ng/ml of omeprazole sulfide in plasma;
(26)Phenylbutazone: 0.3 mcg/ml in plasma;
(27)Prednisolone: 1 ng/ml in plasma;
(28)Procaine penicillin: 25 ng/ml of procaine in plasma;
(29)Ranitidine: 40 ng/ml in plasma;
(30)Triamcinolone acetonide: 100 pg/ml in plasma; and
(31)Xylazine: 200 pg/ml in plasma.
(b)A laboratory finding that a horse has not exceeded a threshold set forth in this section shall not constitute a defense to a violation of any other section of this Subchapter.
(c)Special provisions.
(1)Cobalt. A person who is found responsible for a violation of this section for the substance cobalt, when the detected concentration of cobalt exceeds 300 ng/ml in plasma, shall incur the same penalty described in section 4043.12(b)(2) of this Part.
(2)Corticosteroid joint injection. It shall not be a violation of this section for the drug betamethasone, isoflupredone or triamcinolone acetonide when:
(i)the laboratory positive resulted from an administration that was recorded in the contemporaneous veterinary records of the horse, reported to the commission in compliance with section 4043.4(b) of this Part before the horse raced, and administered to the horse in compliance with section 4043.2(i) of this Part at least seven days before the race; and
(ii)the commission had not previously issued a warning to the trainer that the commission laboratory reported finding such substance, in a urine or blood sample collected from any horse trained by such trainer, at a concentration in excess of the threshold set forth in subdivision (a) of this section.